Home
HelpTest ID BLOD0036 Butalbital, Serum
Useful For
Monitoring butalbital therapy
Specimen Type
Serum RedSpecimen Required
Supplies: Sarstedt Aliquot Tube, 5 mL (T914)
Collection Container/Tube: Red top (serum gel/SST are not acceptable)
Submission Container/Tube: Plastic vial
Specimen Volume: 1.5 mL
Collection Instructions:
1. Draw blood immediately before the next scheduled dose.
2. Within 2 hours of collection centrifuge and aliquot serum into a plastic vial.
Reject Due To
| Gross hemolysis | OK |
| Gross lipemia | OK |
| Gross icterus | OK |
Specimen Minimum Volume
0.6 mL
Specimen Stability Information
| Specimen Type | Temperature | Time |
|---|---|---|
| Serum Red | Refrigerated (preferred) | 28 days |
| Ambient | 28 days | |
| Frozen | 28 days |
Day(s) Performed
Thursday
Report Available
3 to 9 daysMethod Name
Gas Chromatography-Mass Spectrometry (GC-MS)
Performing Laboratory
Mayo Clinic Laboratories in Rochester
CPT Code Information
80299
Reporting Name
Butalbital, SReference Values
Peak concentrations (100 mg single oral dose):
1.7-2.6 at 2 hours
1.3-1.7 at 24 hours
Toxic concentration: ≥10 mcg/mL
Cutoff concentrations by gas chromatography mass spectrometry:
Butalbital: 0.5 ng/mL
Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.Forms
If not ordering electronically, complete, print, and send a Therapeutics Test Request (T831) with the specimen.
Secondary ID
8427SANFORD INTERFACE BUILD INFORMATION
| Result Code | Result Code Description |
|---|---|
| 5749 | Butalbital |